Hyperglycemia and Hypoglycemia Are Associated with In-Hospital Mortality among Patients with Coronavirus Disease 2019 Supported with Extracorporeal Membrane Oxygenation
Abstrak
Metabolic abnormalities, such as preexisting diabetes or hyperglycemia or hypoglycemia during hospitalization aggravated the severity of COVID-19. We evaluated whether diabetes history, hyperglycemia before and during extracorporeal membrane oxygenation (ECMO) support, and hypoglycemia were risk factors for mortality in patients with COVID-19. This study included data on 195 patients with COVID-19, who were aged ≥19 years and were treated with ECMO. The proportion of patients with diabetes history among nonsurvivors was higher than that among survivors. Univariate Cox regression analysis showed that in-hospital mortality after ECMO support was associated with diabetes history, renal replacement therapy (RRT), and body mass index (BMI) 200 mg/dL and glucose levels before ventilator >200 mg/dL were not associated with in-hospital mortality. However, glucose levels before ECMO >200 mg/dL and minimal glucose levels during hospitalization 200 mg/dL before ECMO and minimal glucose 200 mg/dL before ECMO and minimal glucose level <70 mg/dL during hospitalization were risk factors for in-hospital mortality among COVID-19 patients who underwent ECMO.
Topik & Kata Kunci
Penulis (26)
Kukhui Son
W. Kim
J. Kwak
C. Choi
S. Lee
Ui Won Ko
Hyoung-Soo Kim
Haeyoung Lee
Euysuk Chung
Jae-Bum Kim
W. Jang
J. Jung
Jieon Kim
Y. Yoon
Seunghwan Song
M. Sung
M. Jang
Y. Kim
I. Jeong
Do Wan Kim
T. Kim
Soon Jin Kim
Su Wan Kim
J. Hong
H. An
On Behalf Of The Korean Society For Thoracic And C
Format Sitasi
Akses Cepat
- Tahun Terbit
- 2022
- Bahasa
- en
- Total Sitasi
- 4×
- Sumber Database
- Semantic Scholar
- DOI
- 10.3390/jcm11175106
- Akses
- Open Access ✓